vTv Therapeutics Inc.VTVTNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank50
3Y CAGR+13.1%
5Y CAGR+10.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+13.1%/yr
vs -14.4%/yr prior
5Y CAGR
+10.1%/yr
Consistent
Acceleration
+27.5pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$17.86M+54.7%
2024$11.55M-15.1%
2023$13.60M+10.0%
2022$12.36M-7.3%
2021$13.32M+21.0%
2020$11.02M-27.1%
2019$15.12M-34.4%
2018$23.04M-41.9%
2017$39.64M-13.4%
2016$45.75M-